Reconciled ClinicalTrials.gov v2 Protocol Specification
| Protocol Field | Verified Registry Value |
|---|---|
| NCT Identifier | NCT07028697 |
| Consolidated Lead Sponsor | Nxera Pharma Korea Co |
| Therapeutic Condition Cohort | Neurology, Psychiatry, and Pain |
| Clinical Trial Phase | Phase III |
| Overall Recruitment Status | COMPLETED |
| Registered Enrollment | 164 participants (ACTUAL) |
| Registered Start Date | 2024-12-04 |
| WhyStopped Classification | Not Stopped |
Named U.S. Hospital Clinical Research Sites
| Hospital Research Site | Location | Site Profile |
|---|---|---|
| Chungnam National University Hospital | Daejeon, South Korea | Open Hospital Dossier -> |
| Chonnam National University Hospital | Gwangju, South Korea | Open Hospital Dossier -> |
| Gachon University Gil Medical Center | Incheon, South Korea | Open Hospital Dossier -> |
| Seoul National University Bundang Hospital | Seongnam-si, South Korea | Open Hospital Dossier -> |
Search related sites and sponsors in the Interactive Directory, explore Neurology, Psychiatry, and Pain Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.